13D Filings
Climb Bio, Inc.
CLYM
Amendment
Ownership

0.00%

Total Shares

0

Issuer CIK

1768446

CUSIP

28658R106

Event Date

Oct 13, 2025

Accepted

Oct 16, 2025, 05:48 PM

Reporting Persons (4)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
AI ETI LLC
Other
0.00%000
Access Industries Holdings LLC
Other
0.00%000
Access Industries Management, LLC
Other
0.00%000
Len Blavatnik
Individual
0.00%000
Disclosure Items (3)

Security Title

Common Stock, par value $0.0001 per share

Issuer Name

Climb Bio, Inc.

Issuer Address

20 William Street, Wellesley Hills, MA, 02481

Percentage of Class

The disclosure in Items 5(a), (b),(c) and (e) is hereby amended and restated as follows: (a) (b) The responses of each of the Reporting Persons with respect to Rows 11, 12, and 13 of the cover pages of this Schedule 13D that relate to the aggregate number and percentage of shares of Common Stock (including but not limited to footnotes to such information) are incorporated herein by reference.

Number of Shares

The responses of each of the Reporting Persons with respect to Rows 7, 8, 9, and 10 of the cover pages of this Schedule 13D that relate to the number of shares of Common Stock as to which each of the persons or entities referenced in Item 2 above has sole or shared power to vote or to direct the vote of and sole or shared power to dispose of or to direct the disposition of (including but not limited to footnotes to such information) are incorporated herein by reference.

Transactions

On October 14, 2025, AI ETI sold 750,000 shares of Common Stock at a price of $1.9202 per share in a block trade. On October 16, 2025, AI ETI sold 1,000,000 shares of Common Stock and 2,085,117 shares of Common Stock each in a separate block trade at a price of $1.95 per share.

Date of 5% Ownership

As of October 14, 2025, each of the Reporting Persons ceased to be the beneficial owner of more than five percent of the Issuer's shares of Common Stock.

99.9 Joint Filing Agreement, dates as of October 16, 2025.

Climb Bio, Inc. — Schedule 13D | 13D Filings